News & Events about Kymera Therapeutics Inc.
Market News Video
1month ago
In trading on Thursday, shares of Kymera Therapeutics Inc (KYMR) crossed below their 200 day moving average of 29.07, changing hands as low as 26.43 per share. Kymera Therapeutics Inc shares are currently trading down about 13.4% on the day...
InvestorPlace
2 months ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.
The post 7 Biotech Stocks to Buy for 100% Returns appeared first on InvestorPlace...
Kymera Therapeutics, Inc. (NASDAQ:KYMR Get Rating) has earned an average rating of Hold from the eleven brokerages that are currently covering the stock, MarketBeat.com reports. Five research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The ...
Globe Newswire
5 months ago
WATERTOWN, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the Company will present at the 41st Annual J.P...